BeyondSpring Inc. Increase (Decrease) in Other Current Liabilities
BeyondSpring Inc. (BYSI) reported Increase (Decrease) in Other Current Liabilities of $710.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentLiabilities · last filed 2026-08-14
- BeyondSpring Inc. increase (decrease) in other current liabilities for the quarter ending 2026-06-30 was $235.00K.
- BeyondSpring Inc. increase (decrease) in other current liabilities for the quarter ending 2026-03-31 was $475.00K, a 37.17% decline year-over-year.
- BeyondSpring Inc. increase (decrease) in other current liabilities for the quarter ending 2025-12-31 was $22.00K.
- BeyondSpring Inc. increase (decrease) in other current liabilities for the quarter ending 2025-09-30 was $308.00K, a 18.01% increase year-over-year.
- BeyondSpring Inc. increase (decrease) in other current liabilities for fiscal 2025 was $268.00K.
- BeyondSpring Inc. increase (decrease) in other current liabilities for fiscal 2024 was -$163.00K, a 244.25% decline from fiscal 2023.
- BeyondSpring Inc. increase (decrease) in other current liabilities for fiscal 2023 was $113.00K.
| Period end | Increase (Decrease) in Other Current Liabilities 3 month | Increase (Decrease) in Other Current Liabilities 6 month | Increase (Decrease) in Other Current Liabilities 9 month | Increase (Decrease) in Other Current Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $235.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $710.00K 10-Q · filed 2026-08-14 | $732.00K derived: sum of 3 quarters · filed 2026-08-14 | $1.04M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $475.00K 10-Q · filed 2026-05-13 | $497.00K derived: sum of 2 quarters · filed 2026-05-13 | $805.00K derived: sum of 3 quarters · filed 2026-05-13 | -$13.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $330.00K derived: sum of 2 quarters · filed 2026-03-25 | -$488.00K derived: sum of 3 quarters · filed 2026-08-14 | $268.00K 10-K · filed 2026-03-25 |
| 2025-09-30 | $308.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$510.00K derived: sum of 2 quarters · filed 2026-08-14 | $246.00K 10-Q · filed 2025-11-12 | -$213.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$818.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$62.00K 10-Q · filed 2026-08-14 | -$521.00K derived: sum of 3 quarters · filed 2026-08-14 | -$260.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $756.00K 10-Q · filed 2026-05-13 | $297.00K derived: sum of 2 quarters · filed 2026-05-13 | $558.00K derived: sum of 3 quarters · filed 2026-05-13 | $792.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$459.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$198.00K derived: sum of 2 quarters · filed 2026-03-25 | $36.00K derived: sum of 3 quarters · filed 2026-03-25 | -$163.00K 10-K · filed 2026-03-25 |
| 2024-09-30 | $261.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $495.00K derived: sum of 2 quarters · filed 2025-11-12 | $296.00K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $234.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $35.00K 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | -$199.00K 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | $113.00K 10-K · filed 2025-03-27 | |||
| 2022-12-31 | -$4.67M 20-F · filed 2023-04-18 | |||
| 2021-12-31 | $743.00K derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | $3.24M derived: sum of 2 quarters · filed 2023-04-18 | $2.54M 20-F · filed 2023-04-18 | |
| 2021-09-30 | $2.49M derived: 6-K 9 month − 6-K 6 month · filed 2021-12-30 | $1.79M 6-K · filed 2021-12-30 | ||
| 2021-06-30 | -$702.00K 6-K · filed 2021-09-10 | |||
| 2020-12-31 | $1.87M derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | $2.44M derived: sum of 2 quarters · filed 2023-04-18 | $2.37M 20-F · filed 2023-04-18 | |
| 2020-09-30 | $567.00K derived: 6-K 9 month − 6-K 6 month · filed 2021-12-30 | $502.00K 6-K · filed 2021-12-30 | ||
| 2020-06-30 | -$65.00K 6-K · filed 2021-09-10 | |||
| 2019-12-31 | -$275.00K 20-F · filed 2022-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |